First Time Loading...

Takara Bio Inc
TSE:4974

Watchlist Manager
Takara Bio Inc Logo
Takara Bio Inc
TSE:4974
Watchlist
Price: 1 008 JPY 1.92%
Updated: Apr 23, 2024

Intrinsic Value

Takara Bio, Inc. engages in development and marketing of genetic engineering technologies. [ Read More ]

The intrinsic value of one Takara Bio Inc stock under the Base Case scenario is 902.83 JPY. Compared to the current market price of 1 008 JPY, Takara Bio Inc is Overvalued by 10%.

Key Points:
Intrinsic Value
Base Case
902.83 JPY
Overvaluation 10%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Takara Bio Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Takara Bio Inc stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Takara Bio Inc

Provide an overview of the primary business activities
of Takara Bio Inc.

What unique competitive advantages
does Takara Bio Inc hold over its rivals?

What risks and challenges
does Takara Bio Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Takara Bio Inc.

Provide P/S
for Takara Bio Inc.

Provide P/E
for Takara Bio Inc.

Provide P/OCF
for Takara Bio Inc.

Provide P/FCFE
for Takara Bio Inc.

Provide P/B
for Takara Bio Inc.

Provide EV/S
for Takara Bio Inc.

Provide EV/GP
for Takara Bio Inc.

Provide EV/EBITDA
for Takara Bio Inc.

Provide EV/EBIT
for Takara Bio Inc.

Provide EV/OCF
for Takara Bio Inc.

Provide EV/FCFF
for Takara Bio Inc.

Provide EV/IC
for Takara Bio Inc.

Show me price targets
for Takara Bio Inc made by professional analysts.

What are the Revenue projections
for Takara Bio Inc?

How accurate were the past Revenue estimates
for Takara Bio Inc?

What are the Net Income projections
for Takara Bio Inc?

How accurate were the past Net Income estimates
for Takara Bio Inc?

What are the EPS projections
for Takara Bio Inc?

How accurate were the past EPS estimates
for Takara Bio Inc?

What are the EBIT projections
for Takara Bio Inc?

How accurate were the past EBIT estimates
for Takara Bio Inc?

Compare the revenue forecasts
for Takara Bio Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Takara Bio Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Takara Bio Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Takara Bio Inc compared to its peers.

Compare the P/E ratios
of Takara Bio Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Takara Bio Inc with its peers.

Analyze the financial leverage
of Takara Bio Inc compared to its main competitors.

Show all profitability ratios
for Takara Bio Inc.

Provide ROE
for Takara Bio Inc.

Provide ROA
for Takara Bio Inc.

Provide ROIC
for Takara Bio Inc.

Provide ROCE
for Takara Bio Inc.

Provide Gross Margin
for Takara Bio Inc.

Provide Operating Margin
for Takara Bio Inc.

Provide Net Margin
for Takara Bio Inc.

Provide FCF Margin
for Takara Bio Inc.

Show all solvency ratios
for Takara Bio Inc.

Provide D/E Ratio
for Takara Bio Inc.

Provide D/A Ratio
for Takara Bio Inc.

Provide Interest Coverage Ratio
for Takara Bio Inc.

Provide Altman Z-Score Ratio
for Takara Bio Inc.

Provide Quick Ratio
for Takara Bio Inc.

Provide Current Ratio
for Takara Bio Inc.

Provide Cash Ratio
for Takara Bio Inc.

What is the historical Revenue growth
over the last 5 years for Takara Bio Inc?

What is the historical Net Income growth
over the last 5 years for Takara Bio Inc?

What is the current Free Cash Flow
of Takara Bio Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Takara Bio Inc.

Financials

Balance Sheet Decomposition
Takara Bio Inc

Current Assets 61.9B
Cash & Short-Term Investments 35.3B
Receivables 8.4B
Other Current Assets 18.2B
Non-Current Assets 61.1B
PP&E 50.5B
Intangibles 8.8B
Other Non-Current Assets 1.8B
Current Liabilities 8.3B
Accounts Payable 3.8B
Accrued Liabilities 870m
Other Current Liabilities 3.7B
Non-Current Liabilities 2.5B
Other Non-Current Liabilities 2.5B
Efficiency

Earnings Waterfall
Takara Bio Inc

Revenue
47.7B JPY
Cost of Revenue
-21.3B JPY
Gross Profit
26.4B JPY
Operating Expenses
-24.9B JPY
Operating Income
1.5B JPY
Other Expenses
97m JPY
Net Income
1.6B JPY

Free Cash Flow Analysis
Takara Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Takara Bio Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Operating Income
Positive Free Cash Flow
Positive 3-Year Average ROIC
54/100
Profitability
Score

Takara Bio Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Takara Bio Inc's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
93/100
Solvency
Score

Takara Bio Inc's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Takara Bio Inc

Wall Street analysts forecast Takara Bio Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Takara Bio Inc is 2 040 JPY with a low forecast of 1 313 JPY and a high forecast of 2 835 JPY.

Lowest
Price Target
1 313 JPY
30% Upside
Average
Price Target
2 040 JPY
102% Upside
Highest
Price Target
2 835 JPY
181% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Takara Bio Inc

1M 1M
+2%
6M 6M
-21%
1Y 1Y
-41%
3Y 3Y
-63%
5Y 5Y
-56%
10Y 10Y
-12%
Annual Price Range
1 008
52w Low
941
52w High
1 772
Price Metrics
Average Annual Return -4.11%
Standard Deviation of Annual Returns 32.42%
Max Drawdown -71%
Shares Statistics
Market Capitalization 121.4B JPY
Shares Outstanding 120 415 600
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Takara Bio Inc Logo
Takara Bio Inc

Country

Japan

Industry

Biotechnology

Market Cap

121.4B JPY

Dividend Yield

6.05%

Description

Takara Bio, Inc. engages in development and marketing of genetic engineering technologies. The company is headquartered in Kusatsu-Shi, Shiga-Ken and currently employs 1,539 full-time employees. The company went IPO on 2004-12-07. The firm operates in three business segments. Bioindustry Support segment provides reagents for research (genetic engineering reagents, cell engineering reagents, protein engineering reagents), scientific instruments, contract services and license fees for gene related patents to research institutes, such as universities and companies where biotechnology research and development are conducted. Gene Medicine segment provides gene therapy-related development and sale licensing fees and trial products as an application field of genetic engineering technology and cell engineering technology which is core technology cultivated in development of research reagents. Medical Food and Biotechnology segment provides health food and health food research and development services, license fees for health food related patents, as well as license fees for mushrooms.

Contact

SHIGA-KEN
Kusatsu-shi
7-4-38, Noji-Higashi
+81775656920.0
http://www.takara-bio.co.jp/

IPO

2004-12-07

Employees

1 539

Officers

CEO, President & Representative Director
Mr. Koichi Nakao
Senior Executive Officer & Director
Dr. Yoh Hamaoka Ph.D.
VP, Executive Officer & Director
Mr. Junichi Mineno Ph.D.
Executive Officer
Mr. Masanobu Kimura M.S., R.Ph.
Senior Managing Executive Officer & Director
Katsuhiko Kusakabe
Head of Research and Development
Mr. Andrew Farmer Ph.d.
Show More
Managing Executive Officer
Kyoko Nakajima
Show Less

See Also

Discover More
What is the Intrinsic Value of one Takara Bio Inc stock?

The intrinsic value of one Takara Bio Inc stock under the Base Case scenario is 902.83 JPY.

Is Takara Bio Inc stock undervalued or overvalued?

Compared to the current market price of 1 008 JPY, Takara Bio Inc is Overvalued by 10%.